Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Oct 8, 2023, 18:03 |
Insight
Bishal Gyawali: Kudos to the FDA for being proactive and swift in making withdrawal recommendations in recent years.
Bishal Gyawali, Associate Professor at Queen's University, shared on X/Twitter: "When a drug that previously…
Oct 6, 2023, 16:09 |
Blog
Giselle Sholler: The FDA-ODAC said YES to DFMO!!
Quoting Giselle Sholler, Division Chief Pediatric Hematology, Oncology, BMT at Penn State Health Children's Hospital,…
Oct 2, 2023, 18:25 |
Blog
W. Michael Korn: The FDA just granted marketing authorization for the Invitae Common Hereditary Cancers Panel.
W. Michael Korn, Chief Medical Officer for Oncology at Invitae, shared on LinkedIn: “The FDA…
Oct 1, 2023, 16:07 |
Blog
Vivek Subbiah: Fantastic keynote lecture on “The FDA perspective on early phase pre-market dose optimization” by the amazing Dr. Paul Kluetz.
Vivek Subbiah shared on X/Twitter: “Fantastic keynote lecture on “The FDA perspective on early phase pre-market…
Oct 1, 2023, 00:13 |
Insight
Ruben Mesa: Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times!
Ruben Mesa, President at Atrium Health Levine Cancer, Executive Director at Atrium Health Wake Forest…
Sep 27, 2023, 17:55 |
Drugs
Julia Maués: Sept 25, 1998, 23 yrs ago, FDA Oncology approved genentech’s Herceptin. But the biggest prize? TIME.
Julia Maués, recently shared on Twitter: "Sept 25, 1998, 23 yrs ago, FDA Oncology approved genentech’s…
Sep 12, 2023, 19:59 |
Insight
Bishal Gyawali: In this perspective piece out in NEJM today, we discuss finding the right balance for accelerated approval of cancer drugs in the context of the recently proposed FDA guidance.
Sep 3, 2023, 20:57 |
Blog
Thor Halfdanarson: Trial Alert! ACTION-1 is now open at all three Mayo Clinic sites.
Thor Halfdanarson, GI oncologist with a focus on neuroendocrine tumors (NETs) and Vice President for…
Aug 30, 2023, 17:53 |
Blog
Christopher Clinton Conway: Los Angeles now offers the only FDA-cleared safe, noninvasive quantitative transmission ultrasound in the QT Imaging Breast Center, Los Angeles at Beverly Hills, A Project of the Dr. Susan Love Foundation.
Aug 16, 2023, 19:43 |
Drugs
Arndt Vogel: FDA approves Melphalan as a liver-directed treatment for uveal melanoma.
Arndt Vogel, Head of the GI-Cancer Center and of the Center for Personalized Medicine at…
23
24
25
26
27
All:
941
Posts:
241 - 250
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube